Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| secretory cell | 6 studies | 37% ± 21% | |
| brush cell | 6 studies | 41% ± 14% | |
| ciliated cell | 6 studies | 36% ± 18% | |
| respiratory goblet cell | 5 studies | 28% ± 16% | |
| epithelial cell | 5 studies | 28% ± 10% | |
| ionocyte | 4 studies | 39% ± 7% | |
| basal cell | 4 studies | 43% ± 19% | |
| germinal center B cell | 4 studies | 28% ± 4% | |
| B cell | 3 studies | 29% ± 8% | |
| club cell | 3 studies | 33% ± 9% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| lung | 3 studies | 39% ± 25% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 95% | 509.40 | 232 / 245 | 100% | 106.01 | 501 / 502 |
| stomach | 76% | 298.75 | 274 / 359 | 97% | 66.50 | 276 / 286 |
| pancreas | 82% | 57.26 | 268 / 328 | 91% | 66.09 | 162 / 178 |
| lung | 73% | 61.60 | 423 / 578 | 83% | 37.40 | 964 / 1155 |
| intestine | 54% | 196.80 | 521 / 966 | 97% | 75.28 | 511 / 527 |
| breast | 60% | 228.41 | 276 / 459 | 91% | 52.59 | 1014 / 1118 |
| esophagus | 39% | 151.91 | 569 / 1445 | 91% | 41.72 | 166 / 183 |
| bladder | 43% | 57.71 | 9 / 21 | 80% | 41.61 | 402 / 504 |
| thymus | 95% | 84.02 | 622 / 653 | 25% | 7.03 | 151 / 605 |
| adrenal gland | 97% | 88.88 | 250 / 258 | 14% | 6.01 | 32 / 230 |
| kidney | 100% | 142.07 | 89 / 89 | 11% | 1.98 | 95 / 901 |
| ovary | 11% | 6.28 | 20 / 180 | 90% | 44.77 | 387 / 430 |
| spleen | 97% | 115.24 | 233 / 241 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 93% | 253.32 | 27 / 29 |
| peripheral blood | 92% | 197.15 | 855 / 929 | 0% | 0 | 0 / 0 |
| skin | 72% | 91.75 | 1296 / 1809 | 18% | 3.44 | 84 / 472 |
| uterus | 9% | 10.44 | 15 / 170 | 77% | 46.01 | 352 / 459 |
| tonsil | 0% | 0 | 0 / 0 | 82% | 37.57 | 37 / 45 |
| liver | 8% | 3.09 | 17 / 226 | 19% | 4.86 | 76 / 406 |
| eye | 0% | 0 | 0 / 0 | 9% | 1.47 | 7 / 80 |
| adipose | 4% | 2.06 | 46 / 1204 | 0% | 0 | 0 / 0 |
| heart | 3% | 0.99 | 22 / 861 | 0% | 0 | 0 / 0 |
| blood vessel | 2% | 0.73 | 21 / 1335 | 0% | 0 | 0 / 0 |
| brain | 1% | 0.67 | 20 / 2642 | 0% | 1.77 | 2 / 705 |
| muscle | 0% | 0.04 | 1 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0090200 | Biological process | positive regulation of release of cytochrome c from mitochondria |
| GO_0008584 | Biological process | male gonad development |
| GO_0006915 | Biological process | apoptotic process |
| GO_0008637 | Biological process | apoptotic mitochondrial changes |
| GO_0042981 | Biological process | regulation of apoptotic process |
| GO_0031334 | Biological process | positive regulation of protein-containing complex assembly |
| GO_0031966 | Cellular component | mitochondrial membrane |
| GO_0097136 | Cellular component | Bcl-2 family protein complex |
| GO_0012505 | Cellular component | endomembrane system |
| GO_0005515 | Molecular function | protein binding |
| Gene name | BIK |
| Protein name | Bcl-2-interacting killer (Apoptosis inducer NBK) (BIP1) (BP4) |
| Synonyms | NBK |
| Description | FUNCTION: Accelerates programmed cell death. Association to the apoptosis repressors Bcl-X(L), BHRF1, Bcl-2 or its adenovirus homolog E1B 19k protein suppresses this death-promoting activity. Does not interact with BAX. . |
| Accessions | Q13323 ENST00000216115.3 |
